Share on StockTwits
 

Analysts at UBS AG upped their price target on shares of Omnicare (NYSE:OCR) from $53.00 to $64.00 in a research report issued to clients and investors on Friday, Stock Ratings Network.com reports. The firm currently has a “neutral” rating on the stock. UBS AG’s price target points to a potential upside of 1.01% from the stock’s previous close.

A number of other firms have also recently commented on OCR. Analysts at Barclays raised their price target on shares of Omnicare from $60.00 to $66.00 in a research note to investors on Wednesday, January 8th. They now have an “equal weight” rating on the stock. Analysts at Goldman Sachs Group Inc. raised their price target on shares of Omnicare from $59.00 to $62.00 in a research note to investors on Tuesday, December 17th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $62.00.

Omnicare (NYSE:OCR) traded down 1.22% during mid-day trading on Friday, hitting $62.59. The stock had a trading volume of 262,847 shares. Omnicare has a one year low of $36.31 and a one year high of $64.15. The stock has a 50-day moving average of $60.52 and a 200-day moving average of $56.20. The company has a market cap of $6.446 billion and a P/E ratio of 69.86.

Omnicare, Inc (NYSE:OCR) is a healthcare services company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.